BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34130784)

  • 1. [Clinical features and prognosis of pediatric acute megakaryocytic leukemia].
    Luo TM; Yu J; An XZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Jun; 23(6):613-620. PubMed ID: 34130784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and Prognostic Features in Pediatric Acute Megakaryoblastic Leukemia Without Down Syndrome: A Retrospective Study in China.
    Wang Y; Lu A; Jia Y; Zuo Y; Zhang L
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e301-e308. PubMed ID: 33257285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience.
    Athale UH; Razzouk BI; Raimondi SC; Tong X; Behm FG; Head DR; Srivastava DK; Rubnitz JE; Bowman L; Pui CH; Ribeiro RC
    Blood; 2001 Jun; 97(12):3727-32. PubMed ID: 11389009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
    Qi H; Mao Y; Cao Q; Sun X; Kuai W; Song J; Ma L; Hong Z; Hu J; Zhou G
    Med Sci Monit; 2020 Jun; 26():e922662. PubMed ID: 32532951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
    Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric
    Huang J; Hu G; Suo P; Bai L; Cheng Y; Wang Y; Zhang X; Liu K; Sun Y; Xu L; Kong J; Yan C; Huang X
    Front Oncol; 2023; 13():1116205. PubMed ID: 36874138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
    Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of multicenter study based on childhood acute lymphoblastic leukemia 2005 protocol].
    Cai JY; Wang NL; Jiang H; Shen SH; Xue HL; Chen J; Pan C; Gao YJ; Sun LR; Yuan XJ; Gu LJ; Tang JY
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):511-517. PubMed ID: 29996184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome.
    Hama A; Taga T; Tomizawa D; Muramatsu H; Hasegawa D; Adachi S; Yoshida N; Noguchi M; Sato M; Okada K; Koh K; Mitsui T; Takahashi Y; Miyamura T; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Br J Haematol; 2023 May; 201(4):747-756. PubMed ID: 36786154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
    Inaba H; Zhou Y; Abla O; Adachi S; Auvrignon A; Beverloo HB; de Bont E; Chang TT; Creutzig U; Dworzak M; Elitzur S; Fynn A; Forestier E; Hasle H; Liang DC; Lee V; Locatelli F; Masetti R; De Moerloose B; Reinhardt D; Rodriguez L; Van Roy N; Shen S; Taga T; Tomizawa D; Yeoh AE; Zimmermann M; Raimondi SC
    Blood; 2015 Sep; 126(13):1575-84. PubMed ID: 26215111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
    Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical analysis on adult acute T-lymphoblastic leukemia].
    Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of measurable residual disease based on multiparameter flow cytometry in childhood acute myeloid leukemia.
    Huo Y; Guan XM; Dou Y; Wen XH; Guo YX; Shen YL; An XZ; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Nov; 23(11):1111-1118. PubMed ID: 34753542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
    Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
    Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic Leukemia without Down Syndrome].
    Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Analysis of Pediatric Acute Myeloid Leukemia with CCLG-AML 2015 Regimen].
    Wang P; Xiong H; Li JX; Wang Z; Yang L; Tao F; Chen Z; DU Y; Zhang AP; Luo LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):373-380. PubMed ID: 35395966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical Significance of Minimal Residual Disease in Risk Stratification and Prognosis of Childhood B-lineage Acute Lymphoblastic Leukemia].
    An FY; Zhang SH; Kong LJ; Liang Y; Xu JX; He HL; Chai YH; Zhao WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):729-735. PubMed ID: 28641626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.